Skip to content

Clinical Significance and Coexistence of Polymorphisms of Individual Collagen-coding Genes

Clinical Significance and Coexistence of Polymorphisms of Individual Collagen-coding Genes - rs1800012 of the COL1A1 Gene and rs12722 of the COL5A1 Gene in Patellar Instability in Children.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05763108
Enrollment
250
Registered
2023-03-10
Start date
2022-04-01
Completion date
2023-12-20
Last updated
2024-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ligament; Laxity, Recurrent Patellar Dislocation

Brief summary

The purpose of this study is to assess correlation between recurrent patella dislocation and genetic polymorphism rs1800012 of the COL1A1 Gene and rs12722 of the COL5A1 Gene.

Detailed description

After being informed about the study and potential risk all of participants were performed phisical examination and genetic test. In the study we established two groups: In first group- 50 patients with recurrent patellar dislocation and without any genetic disorders. In the second one 200 patients without recurrent patellar dislocation and genetic disorders. All pediatric patients were between 7 and 17 years old in two groups respectivly.

Interventions

DIAGNOSTIC_TESTgenetic test

COL1A1 or COL5A1 genetic test

OTHERBeighton joint laxity test

Based on Beighton scale.

Sponsors

Polish Mother Memorial Hospital Research Institute
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
7 Years to 17 Years
Healthy volunteers
Yes

Inclusion criteria

• First-time diagnosed or recurrent patellar dislocation patient from 7 to 17 age years old.

Exclusion criteria

* Patient's age under 7. * Presence of genetic diseases such as: Down's syndrome or Marfan's syndrome. * Metabolic disorders. * Previous knee surgeries. * Cartilage and bone fractures in the knee. * No consent for examination from the legal guardian.

Design outcomes

Primary

MeasureTime frameDescription
Patients with recurrent patellar dislocation2022-2023Patients with recurrent patellar dislocation
Control group without obvious joint hipermobility2022-2023Control group without obvious joint hipermobility

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026